View of Repurposing FDA-approved drugs against the Crimean-Congo haemorrhagic fever virus: an in silico study

Return to Article Details Repurposing FDA-approved drugs against the Crimean-Congo haemorrhagic fever virus: an in silico study Download Download PDF